Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0K5LX
|
||||
Former ID |
DNC002519
|
||||
Drug Name |
4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [551374] | ||
Structure |
Download2D MOL |
||||
Formula |
C13H10N2O3
|
||||
Canonical SMILES |
C1=CC(=C(C=C1O)O)C2=C3C=CC(=O)C=C3NN2
|
||||
InChI |
1S/C13H10N2O3/c16-7-1-3-9-11(5-7)14-15-13(9)10-4-2-8(17)6-12(10)18/h1-6,14-15,17-18H
|
||||
InChIKey |
CUCRVNUQCLNBQJ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Estrogen receptor | Target Info | Inhibitor | [551374] | |
Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
Signaling events mediated by HDAC Class II | |||||
Plasma membrane estrogen receptor signaling | |||||
LKB1 signaling events | |||||
Regulation of Telomerase | |||||
ATF-2 transcription factor network | |||||
AP-1 transcription factor network | |||||
FOXM1 transcription factor network | |||||
Validated nuclear estrogen receptor alpha network | |||||
Signaling mediated by p38-alpha and p38-beta | |||||
FOXA1 transcription factor network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.